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Summary
Background: Localized actomyosin contraction couples with
actin polymerization and cell-matrix adhesion to regulate cell
protrusions and retract trailing edges of migrating cells.
Although many cells migrate in collective groups during tissue
morphogenesis, mechanisms that coordinate actomyosin
dynamics in collective cell migration are poorly understood.
Migration of Drosophila border cells, a genetically tractable
model for collective cell migration, requires nonmuscle
myosin-II (Myo-II). How Myo-II specifically controls border
cell migration and how Myo-II is itself regulated is largely
unknown.
Results:We show that Myo-II regulates two essential features
of border cell migration: (1) initial detachment of the border cell
cluster from the follicular epithelium and (2) the dynamics of
cellular protrusions. We further demonstrate that the cell
polarity protein Par-1 (MARK), a serine-threonine kinase, regu-
lates the localization and activation of Myo-II in border cells.
Par-1 binds to myosin phosphatase and phosphorylates it at
a known inactivating site. Par-1 thus promotes phosphory-
lated myosin regulatory light chain, thereby increasing Myo-II
activity. Furthermore, Par-1 localizes to and increases active
Myo-II at the cluster rear to promote detachment; in the
absence of Par-1, spatially distinct active Myo-II is lost.
Conclusions: We identify a critical new role for Par-1 kinase:
spatiotemporal regulation of Myo-II activity within the border
cell cluster through localized inhibition of myosin phospha-
tase. Polarity proteins such as Par-1, which intrinsically
localize, can thus directly modulate the actomyosin dynamics
required for border cell detachment and migration. Such a link
between polarity proteins and cytoskeletal dynamics may also
occur in other collective cell migrations.
Introduction
Cells that migrate during embryonic morphogenesis or adult
wound healing often move as cohesive groups, in a process
termed ‘‘collective cell migration’’ [1]. Because collective
migration occurs inmany cancers as part of the tumor invasion
process [1, 2], a better understanding of the mechanisms that
regulate this mode of migration may provide critical insights
into tumor invasion and metastasis. Border cell migration in
the Drosophila ovary is a powerful genetic model system to
identify and dissect conserved molecular pathways that*Correspondence: mcdonaj@ccf.orgcontrol directed collective cell migration (reviewed in [3]).
During late oogenesis, the six to ten follicle cell-derived border
cells form a cohesive group, detach from the follicle cell
monolayer epithelium, and migrate w150 mm between the
germline-derived nurse cells to the anterior border of the
oocyte (Figure 1A; see also Figure S1A available online).
Proteins that regulate the actin cytoskeleton, such as cofilin
and the small GTPase Rac, are essential for proper border
cell migration [4, 5]. Moreover, guidance signaling through
the epidermal growth factor receptor (EGFR) and the
platelet-derived growth factor/vascular-endothelial growth
factor (PDGF/VEGF) receptor related (PVR) promotes Rac-
dependent formation of actin-rich protrusions at the front of
the border cell cluster [5–7]. However, a thorough under-
standing of how the cytoskeleton is dynamically modulated
during border cell migration is still lacking.
We previously demonstrated that Par-1, a cell polarity
protein and serine-threonine kinase, regulates several critical
aspects of border cell migration—the proper detachment of
the border cell cluster from the follicular epithelium and the
directional extension of cell protrusions [8]. Par-1 is known
to cooperate with other polarity proteins to establish static
apical-basal cell polarity, especially in epithelia. Par-1 has
also been implicated in regulation of microtubule stability,
Wnt signaling, and neuronal migration [9]. We determined
that border cell detachment depends on negative regulation
of another polarity protein, Par-3/Bazooka (Baz), by Par-1
[8]. Detachment requires Par-1-dependent restriction of Par-
3/Baz to apical domains of detaching border cells. It is not
clear, however, whether mutually exclusive partitioning of
Par-1 and Par-3/Baz is sufficient for border cell detachment.
Moreover, other aspects of border cell migration such as
protrusion direction, length, and morphology are independent
of Par-3/Baz but dependent on Par-1 [8, 10], suggesting that
Par-1 controls these processes through other partners.
Nonmuscle myosin-II (Myo-II) regulates cell migration [11]
by inducing localized contraction of the actin cytoskeleton, es-
tablishing migrating cell polarity, modulating cell adhesions,
and retracting trailing edges. In Drosophila, Myo-II is required
for epithelial remodeling and movement during tissue and
organ formation, such as occurs during dorsal closure, gastru-
lation, and border cell migration [12, 13]. Myo-II contains two
copies of each of three subunits: the Drosophila heavy chain
(MHC) is Zipper (Zip), the essential light chain is myosin light
chain-cytoplasmic (Mlc-c), and the myosin regulatory light
chain (MRLC) is Spaghetti squash (Sqh). The latter is targeted
by Rho-associated kinase (Rok; also known as ROCK) and
myosin light chain kinase (MLCK) [11, 14], which phosphory-
lateMRLC/Sqh at Thr-18/Ser-19 (Thr-19/Ser-20 inDrosophila).
Phosphorylation of MRLC increases the ATPase activity of
the MHC and stabilizes myosin-containing filaments [11].
Activation by Rok further helps localize Myo-II to cortical cell
membranes and is required for Myo-II function in vivo
[15–18]. Conversely, myosin phosphatase dephosphorylates
MRLC/Sqh to inactivate Myo-II [19].
In this study, we show that active Myo-II modulates both
border cell cluster detachment and the refinement of cellular
protrusions important for cell motility. In turn, Par-1 promotes
Figure 1. Myo-II Regulates Border Cell Detachment and Migration
(A) Egg chambers (subunit of the ovary) of the indicated genotypes stained for F-actin (magenta) and a-tubulin (green). Arrows indicate border cells (yellow)
and follicle cells (FC; white). Scale bar represents 20 mm. Top shows normal border cell migration in control (c306-GAL4/+) stage 9 (left) and stage 10 (right)
egg chambers. Nurse cells (NC) and oocyte are indicated. Bottom shows stage 10 egg chambers expressing UAS-DN-Zip (left) or UAS-Par-1 RNAi Strong
(right) driven by c306-GAL4; border cells did not migrate and are visibly attached to an anterior FC (bracket).
(B) Border cell migration (arrows) in stage 10 sqhAX3mosaic mutant egg chambers stained for E-cadherin (E-cad) (green) to mark cell membranes and DAPI
to mark nuclei (white, insets); clones are marked by loss of nuclear mRFP (magenta). Left shows example of an egg chamber in which a partially mutant
cluster migrated partway to the oocyte. Right shows example of an egg chamber with a completely mutant border cell cluster that did not detach; the
majority of the anterior follicle cells are mutant. Scale bar represents 20 mm. Insets show magnified views of border cell clusters; mutant border cells are
indicated (arrowheads).
(C) Quantification of migration in stage 10 egg chambers of the indicated genotypes, shown as the percentage that did not detach (purple) or detached with
incomplete (white) or complete (green) migration. Error bars represent SEM; nR 350 egg chambers inR 3 experiments.
(D) Frames fromMovie S2 showing a magnified view of the anterior end of an egg chamber expressing UAS-DN-Zip and UAS-mCherry::Jupiter at indicated
times (hr:min); border cells (yellow arrow) are attached to anterior FCs (white arrows). Anterior is to the left for this and subsequent figures.
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364the localized phosphorylation and activation of Myo-II. We
show that Par-1 activates Myo-II by phosphorylating and in-
hibiting the myosin phosphatase complex. Whereas myosin
phosphatase is uniformly distributed, Par-1 is localized to
the rear of the detaching cluster, resulting in phosphatase inhi-
bition andMyo-II activation at the cluster rear. Our results thus
show for the first time that a Par-1/Myo-II regulatory pathway
connects dynamic cell polarity with cytoskeletal dynamics to
regulate collective cell migration.
Results
Myo-II Is Required for Border Cell Detachment and
Protrusion Dynamics
Previous studies found that global loss of sqh (Drosophila
MRLC) throughout the ovary strongly inhibited border cell
migration [13]. In addition, single border cells mutant for sqh
extended long, abnormal protrusions [20]. These studies,
however, did not specifically address which cells require
Myo-II or whether Myo-II regulates other aspects of border
cell migration. To further investigate Myo-II function in border
cell migration, we performed mosaic clonal analysis using
a sqh null allele, sqhAX3 [17]. Border cell clusters containing
at least one mutant border cell exhibited migration defects
and were found anywhere from 25% to 70% of the normal
migration distance (Figure 1B; data not shown). These mutantborder cells were usually located at the back of the cluster
(68%, n = 28), similar to other mutants that disrupt border
cell motility [6]. Inmost of these egg chambers, anterior epithe-
lial follicle cells were also mutant (Figure 1B; data not shown).
Only a few clusters were observed in which all border cells
were mutant (13%, n = 32); in each case, the cluster failed to
detach from the epithelium and did not move away from the
anterior end of the egg chamber (Figure 1B). We then
confirmed that activation of Myo-II is important. We performed
mosaic clonal analysis with a strong mutant allele of rok, rok2
[15], which is a known Myo-II activator. We observed compa-
rable migration defects in egg chambers with rok mosaic
mutant clones (n = 15; data not shown). These results are
consistent with a role for active Myo-II in border cells and
possibly anterior follicle cells.
To better understand why border cells defective for Myo-II
do not migrate, we performed live time-lapse imaging of egg
chambers in culture [7]. Because completely mutant sqh or
rok border cell clusters were difficult to obtain (data not
shown), we knocked down the function of Myo-II in all border
cells using the GAL4/UAS system. A dominant-negative form
of Zip (DN-Zip), which lacks the MHC catalytic motor domain,
disrupts the formation of functional Myo-II [21]. Expression of
DN-Zip in border cells and follicle cells using the follicle cell-
specific driver c306-GAL4 (Figure S1A) significantly inhibited
border cell detachment and migration in fixed egg chambers
Figure 2. Activated Myo-II Is Required Downstream of Par-1
Quantification of migration in stage 10 egg chambers of the indicated genotypes is shown as the percentage of incomplete (yellow) versus complete (green)
migration (A and C) or the percentage with detachment defects (purple) versus detached incomplete (white) or complete (green) migration (B and D). Means
were either not significant (NS; pR 0.05), significant (**; p% 0.01), or very significant (***; p% 0.001), as calculated by the unpaired two-tailed t test. Error
bars represent SEM.
(A and B) Genetic interaction between sqh and par-1 (A) and between rok and par-1 (B); predicted additive effects (dotted line) are shown.
(A) nR 199 egg chambers inR3 experiments (p < 0.001).
(B) nR 81 egg chambers inR3 experiments (p < 0.01 for detachment defect).
(C) Single copies of Sqh wild-type or mutant transgenes in the Par-1 RNAi (strong) background; nR 153 egg chambers inR 3 experiments.
(D) Overexpression ofMLCK, Rok, or the PP1c inhibitor NIPP1, or knockdown ofMbs by RNAi in the Par-1 RNAi (Strong) background; nR 160 egg chambers
inR3 experiments. Par-1 RNAi (Strong) migration defects (Figure 1C) are shown for comparison (B–D).
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365(Figures 1A and 1C). Thus, loss of theMHCZip is similar to loss
of MRLC/Sqh in sqh loss-of-function mosaic clones or Sqh
RNA interference (RNAi) (Figure 1). Using an alternative border
cell driver, slbo-GAL4, we further confirmed that Myo-II was
required in border cells (Figure S1B). The central polar cells
trigger Janus kinase/signal transducer and activator of tran-
scription (JAK/STAT) signaling to recruit surrounding cells to
form the border cell cluster and stimulate their motility [3].
Specific knockdown of Myo-II in polar cells by upd-GAL4 did
not disrupt border cell migration (Figure S1C).
In live egg chambers, control (wild-type) border cells extend
protrusions in the direction of migration, detach from the
epithelium, and migrate to the oocyte over the course of
4–6 hr (Movie S1) [7]. Control protrusions before detachment
are longer in length and lifetime than those that extend after
border cells detach and begin to migrate (Figures S1D–S1F).
Expression of DN-Zip disrupted the ability of someborder cells
to properly detach from the follicle cell epithelium and move
forward (Figure 1D; Movie S2). DN-Zip did not affect the
direction of protrusion extension (data not shown). However,
DN-Zip border cell clusters that did not detach initially had
normal protrusions, but these protrusions failed to resolve
into protrusions of shorter length and duration like in control
(Figures S1E and S1F). Notably, DN-Zip border cell clustersthat detached initially extended protrusions with normal char-
acteristics but after detachment protrusions were slightly
longer in length (p = 0.04; unpaired two-tailed t test) and had
significantly longer lifetime (p = 0.001) than the control (Figures
S1E and S1F).
Activated Myo-II Is Required Downstream of Par-1
in Border Cell Migration
Defects in border cell detachment were also found in border
cells in which Par-1 function was disrupted, either by c306-
GAL4-driven RNAi knockdown (Figures 1A and 1C) or loss-
of-function mosaic clones [8]. Moreover, previously published
studies of border cells mutant for sqh [20] and par-1 [8] re-
ported examples of similar, misshapen long protrusions. We
hypothesized that Par-1 and Myo-II may act in the same
pathway to regulate border cell migration. In support of this,
we identified a genetic interaction between par-1 and sqh (Fig-
ure 2A). Weak expression of RNAi transgenes for Par-1 or Sqh
(UAS-RNAi driven by c306-GAL4) eachmildly disrupted border
cell migration. Coexpression of weak RNAi for both Par-1 and
Sqh dramatically increased the migration defects by 2.5-fold
over the expected additive phenotype. par-1 and rok also
exhibited a genetic interaction (Figure 2B). Stronger RNAi
knockdown of Par-1 (UAS-Par-1 RNAi driven by c306-GAL4
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366in a heterozygous par-1mutant background) significantly dis-
rupted border cell detachment, whereas Rok RNAi disrupted
detachment less frequently. Coexpression of RNAi for both
Par-1 and Rok enhanced the detachment defect to almost
twice the expected additive phenotype. These results indicate
that Rok and Par-1 both regulate border cell detachment,
potentially through a common substrate such as Myo-II.
The interaction between par-1 and sqh led us to investigate
whether Myo-II could suppress the migration defects caused
by loss of par-1. We used a series of transgenes expressing
MRLC/Sqh under the control of the endogenous sqh promoter
[15, 17, 22]. These transgenes are either unmutated (wild-
type), singly mutated at the primary phosphorylation site
(Ser-21), or doubly mutated at the primary and secondary
(Thr-20) phosphorylation sites. Phosphomimetic, active
forms of Sqh (mutation to glutamic acid; E20E21 or E21) and
nonphosphorylatable, inactive Sqh (mutation to alanine;
A20A21) have been shown to respectively rescue or enhance
phenotypes caused by loss of the Myo-II activator rok in
Drosophila [15].
Expression of a single copy of any of the sqh transgenes in
a wild-type background did not disrupt border cell migration
(Figure S2A). Neither nonphosphorylatable sqhA20A21 nor
WT sqh transgenes suppressed the Par-1 RNAi phenotype
(Figure 2C). Conversely, a single copy of either of the phospho-
mimetic mutant transgenes (sqhE21 or sqhE20E21) strongly
suppressed the Par-1 RNAi migration defects (Figure 2C).
Importantly, none of the transgenes suppressed the migration
defects caused by disruption of Par-3/Baz (Figure S2B), a
known target of Par-1 in polarized cells [23] and border cells
[8]. Furthermore, sqh-E21 did not rescue the border cell
motility or detachment defects found in mutants of two other
genes known to regulate border cell migration (Figures S2C
and S2D). These results suggest that activated Myo-II is
specifically required downstream of Par-1. In agreement with
this, overexpression of Par-1 did not rescue the migration
defects caused by Sqh RNAi (Figure S2E).
We next determined whether activation of endogenous
Myo-II could suppress the phenotypes caused by disruption
of Par-1 function. Activation of Myo-II can occur either by
increasingMyo-II kinase levels or by inactivatingmyosin phos-
phatase [11]. Ectopic expression of the Myo-II kinases MLCK
or Rok in vivo leads to greater phosphorylation of MRLC/Sqh
and activation of endogenous Myo-II [11, 24] (see below).
Conversely, myosin phosphatase inactivates Myo-II by de-
phosphorylating MRLC/Sqh and consists of a type 1 protein
phosphatase catalytic subunit (PP1c), a subunit M20 of
unknown function, and the substrate-specific myosin binding
subunit Mbs (also known as MYPT). Therefore, inactivation
of myosin phosphatase increases the activity of Myo-II in cells
[19, 25] (see below). To inhibit myosin phosphatase function
in vivo, we expressed an inhibitor of PP1c, nuclear inhibitor
of PP1 (NIPP1) [26], or Mbs RNAi. Increasing the levels of acti-
vated Myo-II in a WT background, either by overexpressing
Myo-II kinases or inhibiting myosin phosphatase, disrupted
both border cell migration and detachment from the epithelium
(Figure S2F). Thus, border cells, like many migrating cells [11],
require precise levels and/or distribution of active Myo-II for
normal movement. Nonetheless, overexpression of Myo-II
kinases or inhibition of myosin phosphatase efficiently sup-
pressed the Par-1 RNAi-induced border cell detachment and
migration defects (Figure 2D). These results confirm that acti-
vation of Myo-II rescues the detachment and migration
defects caused by loss of par-1.Par-1 Regulates the Distribution and Dynamics of Myo-II
in Border Cells
It has been noted that Myo-II accumulates at cortical
membranes of migrating border cells [13]. Using time-lapse
imaging, we examined the subcellular distribution of a func-
tional GFP-tagged Sqh transgene driven by its own promoter
(Sqh:GFP). This transgene rescues sqhmutant flies to viability
and accurately reports the localization of Myo-II in vivo [22].
Sqh:GFP is highly expressed in live border cells throughout
their migration (Movie S3) and accumulates in transient,
intense fluorescent cortical puncta or ‘‘foci’’ (Figure 3A; Movie
S4); these foci resembled those described in a variety of
epithelia [12, 27–29]. Sqh:GFP foci were particularly evident
where the cluster displayed an obvious change inmorphology,
such as at the cluster rear during detachment (Movie S3; see
below). Control border cell clusters had an average of six
foci per cluster with a median lifetime of 92 s (Figures 3A, 3C,
and 3D; Movie S4).
We asked whether Par-1 influences Sqh:GFP foci in border
cells (Figures 3B–3D; Movie S4). Sqh:GFP was more diffuse
and fewer foci formed in Par-1 RNAi border cells. The foci
that formed had a shortened median lifetime (Figure 3D).
To determine whether Sqh:GFP foci formed in response to
activatedMyo-II, we knockeddownRokor expressed aconsti-
tutively active form of myosin phosphatase (MbsN300) [30]. In
both genotypes, fewer Sqh:GFP foci formed, and they were
less persistent (Figures 3C and 3D; Movie S5; data not shown),
suggesting that Sqh:GFP foci dynamics depend on Myo-II
activation. Thus, Par-1 regulates the localized formation
and/or stability of Myo-II foci in border cells.
Par-1 Regulates the Levels of Activated Myo-II in Border
Cells
To determine whether Par-1 influences Myo-II activity in vivo,
we examined the levels of activatedMRLC/Sqh in border cells.
We used an antibody that specifically recognizes MRLC/Sqh
when it is phosphorylated at the activating Ser-21 (p-MRLC/
Sqh) [11, 17, 18]. Control border cells expressed high levels
of p-MRLC/Sqh at the cell cortex (Figure 4A). Border cells in
which Par-1 (Figure 4B) or the known activator Rok (Figure 4C)
were knocked down by RNAi had reduced levels of p-MRLC/
Sqh compared to control (Figure 4D). In contrast, levels of
the cell-junction protein E-cadherin were unaffected (Figures
4A–4D). Importantly, the overall levels of endogenous MRLC/
Sqh were unchanged when Par-1 was ubiquitously knocked
down (Figure S3A). Conversely, Par-1- or Rok-overexpressing
border cells had quantifiably higher levels of p-MRLC/Sqh
compared to control, but E-cadherin levels were unchanged
(Figures 4E–4H). Furthermore, Mbs RNAi also significantly
increased p-MRLC/Sqh levels (Figures S3B andS3C), confirm-
ing that myosin phosphatase inhibits Myo-II activation in
border cells. Together, these results show that Par-1 promotes
phosphorylation and activation of MRLC/Sqh in vivo.
Par-1 Interacts with and Phosphorylates the Myosin
Phosphatase Complex
We next investigated the mechanistic basis for how Par-1
controls the levels of activated MRLC/Sqh. Kinases such as
Rok activate Myo-II directly by phosphorylating MRLC/Sqh
and indirectly by inactivating myosin phosphatase [19, 24,
25], whereas other kinases, such as NUAK1 and MRCK,
primarily inactivate myosin phosphatase [31, 32]. Myosin
phosphatase is inhibited by phosphorylation of the myosin
binding subunit, Mbs, at several sites including Thr-594
Figure 3. Myo-II Forms Localized Foci in a Par-1-Dependent Manner
(A and B) Frames from time-lapse control (A) and Par-1 RNAi Strong (B) movies (Movie S4) showing Sqh:GFP localization in border cells before detachment
at the indicated times (hr:min:s). Transiently enriched foci (arrowheads) were observed throughout the movies. A stable focus is indicated with an asterisk in
(A). Par-1 RNAi border cells have fewer foci and Sqh:GFP is generally more diffuse than control. Scale bar represents 20 mm.
(C and D) Quantification of mean Sqh:GFP foci number (C) and lifetime (D) in movies of the indicated genotypes. Each point represents the average of
individual foci measured within a single movie. n R 9 movies for each genotype; p % 0.0001 (unpaired two-tailed t test). Error bars represent SEM. See
Supplemental Experimental Procedures for details on analyses.
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367(Thr-696 in mammalian MYPT1) [19, 25]. We did not detect
Par-1 and Sqh in a protein complex; GFP-tagged Par-1 or
Sqh:GFP did not coimmunoprecipitate the respective endoge-
nous proteins from fly extracts (data not shown). Notably,
Par-1 was present in an immunocomplex with myosin phos-
phatase (Figures 5A and 5B; Figures S4A and S4B). Endoge-
nous Mbs was immunoprecipitated from S2 cell (Figure 5A)
and ovarian (Figure S4A) lysates with GFP-tagged Par-1.
Conversely, endogenous Par-1 was immunoprecipitated with
hemagglutinin (HA)-tagged Mbs from S2 cell lysates (Fig-
ure 5B). Flapwing (Flw/PP1b9C; PP1c homolog), a PP1
catalytic subunit that specifically regulates Myo-II [33], also
immunoprecipitated endogenous Par-1 and Mbs from ovarian
and whole fly extracts (Figures S4B and S4C; data not shown).
To test whether Par-1 regulates myosin phosphatase
activity, we used an antibody that recognizes phosphorylated
Drosophila Mbs at a known inhibitory site (p-T594 Mbs; Fig-
ure S4D) [19]. We observed a decrease in p-T594 Mbs levels
in ovarian lysates when Par-1 was ubiquitously knocked
down (Figure 5C). To test whether Par-1 regulates phosphory-
lation of Mbs, we performed an in vitro kinase assay using im-
munopurified HA:Mbs as the substrate (Figure 5D). Addition ofGFP-Par-1 purified from fly lysates or bacterially purified Par-1
catalytic domain [23] increased the levels of p-T594 Mbs
in vitro, whereas kinase-dead Par-1 did not (Figure 5D). Thus,
Par-1 phosphorylatesMbsat the knownThr-594 inhibitory site.
Par-1 Promotes Polarized Distribution of Activated Myo-II
in the Border Cell Cluster
Border cells retain epithelial polarity, especially before they
detach from the epithelium [8, 10], with clear basolateral
(back) and apical (front) sides. Par-1 localizes to the basolat-
eral side of the cluster (Figure 6A) [8]. AlthoughMbs has a fairly
uniform cytoplasmic and cortical localization within the
cluster, Mbs overlaps with Par-1 specifically at the basolateral
side (Figure 6A). In addition, we observed increased Sqh:GFP
signal at the basolateral side of the cluster as it detached (Fig-
ure 6B). Fixed wild-type border cell clusters also exhibited
polarized enrichment of p-MRLC/Sqh (Figures 4A, 6C, and
6D). In some cases this biased enrichment was along the
axis of migration at both the apical and basolateral sides of
the cluster (‘‘front-back bias’’), whereas in others it occurred
at the sides, perpendicular to the axis of migration (‘‘side
bias’’) (Figures 6C and 6D).
Figure 4. Par-1 Regulates Levels of Phosphorylated MRLC/Sqh In Vivo
(A–C and E–G) Representative egg chambers stained for p-MRLC/Sqh (magenta, top panels; white, bottom panels) and E-cadherin (E-cad, green in top
panels) in the indicated genotypes.
(D and H) Quantification of fluorescence intensity in border cells relative to control. Samples were prepared at the same time and images captured using the
same camera exposure. Brightness or contrast of images was adjusted for better visualization but were not used for quantification. Error bars represent
SEM. See Supplemental Experimental Procedures for detailed description of the analyses.
(D) Loss of Par-1 or Rok reduced p-MRLC/Sqh; nR 14 egg chambers inR2 experiments (p% 0.0001; unpaired two-tailed t test). E-cadherin levels were not
altered (pR 0.69).
(H) Overexpression of Par-1 or Rok increased p-MRLC/Sqh levels; n R 10 egg chambers in two experiments (p = 0.0001; unpaired two-tailed t test).
E-cadherin levels were not altered (pR 0.09).
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Par-1 contributes to polarized accumulation of p-MRLC/Sqh
in border cells before they detach. Although the overall levels
of p-MRLC/Sqh were significantly reduced when Par-1 was
knocked down (Figures 4B and 4D), some cortical p-MRLC/
Sqh was still detected (Figures 6C and 6D); however,
p-MRLC/Sqh signal was less polarized (‘‘unbiased’’) than
control (Figure 6D). Par-1 overexpression caused a similar
unbiased distribution, indicating that overall levels of Par-1
activity are important. In contrast, border cell clusters
depleted of Rok by RNAi retained polarized p-MRLC/Sqh,
raising the possibility that Rok regulates p-MRLC/Sqh levels,
but not its distribution. These results indicate that Par-1 not
only regulates the levels of activated MRLC/Sqh but also is
important for the polarized enrichment of p-MRLC/Sqh in
detaching border cells.
Discussion
Myo-II plays a fundamental role in establishing the front-rear
axis of migrating cells to promote directional migration [11].
Myo-II localizes to the cell rear and stimulates motility at the
front [34, 35], likely by local stabilization of adhesions andactomyosin bundles at the cell rear but not at the front [36].
In contrast to single cells, the mechanisms that set up or
maintain polarized actomyosin contraction during collective
migration are still poorly understood. We identified a new
role for Par-1 kinase, namely that Par-1 regulates myosin
phosphatase to control Myo-II activation. We propose amodel
in which Myo-II is activated in a polarized manner (Figures 6E
and 6F). Myosin phosphatase, which is distributed uniformly in
the cluster, is locally inactivated by Par-1 at the basolateral
side (back) of the cluster. The consequent polarization of
active Myo-II induces contraction and cell morphological
changes critical for detachment and motility. The question of
how Par-1 becomes localized to the basolateral side of border
cells is largely unknown. Phosphorylation by the apical polarity
protein aPKC restricts Par-1 to basolateral membranes in
epithelial cells [37] and is also critical for Par-1 function in
border cells [8]. This mechanism may thus restrict basolateral
localization of Par-1 in border cells, although a role for border
cell-specific factors cannot be ruled out.
Our observation that there is an increase in Sqh:GFP at the
rear of the border cell cluster during detachment is consistent
with a specific role for Myo-II in promoting epithelial detach-
ment of border cells. Loss-of-function sqh mosaic clone
Figure 5. Par-1 Is Present in a Complex with Myosin
Phosphatase and Regulates Mbs Phosphorylation
(A) Extracts from S2 cells expressing GFP:Par-1 were
immunoprecipitated with anti-GFP antiserum (IP:
a-GFP) or nonspecific antibody as control (IP: a-IgG).
Blots were probed for Mbs and stripped and reprobed
for GFP and b-tub. Extracts from untransfected S2 cells
were used as a specificity control (lane 4; IP a-GFP*).
(B) Extracts from S2 cells expressing HA:Mbs were
immunoprecipitated with anti-HA antiserum (IP: a-HA)
or nonspecific antibody as control (IP: a-IgG). Twice the
amount of extract was used in lane 4 (IP: a-HA 23). Blots
were probed for Par-1 and HA and stripped and reprobed
for b-tub.
(C) Ovarian lysates from the indicated genotypes were
subjected to western blots with anti-p-Mbs (p-T594)
and Mbs antibodies. Par-1 RNAi (Strong) reduced
p-Mbs levels compared to controls (w1118 orpar-127C1/+).
Intervening lanes on the blot were removed for clarity
(arrowhead).
(D) In vitro kinase assays using either GFP:Par-1 (kinase
dead or full length) immunopurified from whole fly
extracts or bacterially expressed and purifiedMBP:Par-1
catalytic (kinase) domain as sources of kinase. HA:Mbs
was purified from S2 cells and used as the substrate.
Blots were probed for p-T594 Mbs and Mbs. Active
Par-1 kinase increased the levels of p-T594 Mbs (lanes
3 and 4).
Par-1 Controls Myosin Dynamics and Activity
369experiments demonstrated a requirement for Myo-II in border
cells and possibly adjacent epithelial follicle cells. Indeed, live
imaging analyses revealed that disruption of Myo-II function
inhibited the ability of border cells to detach. This raises the
question of how Myo-II contributes to detachment. Activation
of Rok by Rho GTPase can destabilize cell-cell junctions by
inducing actomyosin contraction in normal and tumor-derived
epithelial cells [38]. In other contexts, however, Rho-depen-
dent Myo-II stabilizes cell junctions through regulation of the
junctional protein E-cadherin [39]. The overall levels of E-cad-
herin were unchanged when Rok was knocked down in border
cells, suggesting that activated Myo-II more likely contributes
directly to detachment. We suggest that the localized increase
in activeMyo-II at the rear specifically contracts the border cell
cluster and helps it pull away from the epithelium. In the
absence of Par-1, overall levels of activated Myo-II were
decreased and Sqh:GFP foci, which correlate with active
Myo-II, exhibited altered dynamics; this potentially leads to
uncoordinated or decreased contractile forces and thus to
defects in detachment.
Par-1 promotes increased p-MRLC/Sqh levels and higher
levels of activatedmyosin by phosphorylation of myosin phos-
phatase at a known inactivating threonine. Regulated myosin
phosphatase activity is essential for many cellular processes,
including cell motility and epithelial morphogenesis [19].
Despite identification of kinases that inactivate myosin phos-
phatase in vitro, few have been shown to do so in vivo during
migration. Notably, vertebrate MARK2 (Par-1) phosphorylates
the Mbs homolog MYPT1 in vitro at several sites, including the
conserved threonine examined here [31], although this has not
been confirmed in vivo. This raises the intriguing possibility
that vertebrate Par-1 homologs regulate myosin phosphatase,
and thus Myo-II, during cell migration. However, Par-1-medi-
ated regulation of Myo-II phosphorylation via myosin phos-
phatase may be cell or context specific. In contrast to thesituation in border cells, Par-1 does not colocalize with myosin
phosphatase in Drosophila ovarian epithelial follicle cells;
active p-MRLC/Sqh and Mbs localized to apical domains in
follicle cells whereas Par-1 localizes to basolateral membranes
[18, 23] (data not shown).
Active Myo-II accumulates at the apical side/front of the
border cell cluster in addition to its localization at the rear.
Myo-II that is localized near the leading edge of single cells
has been proposed to promote retraction by coordinating
cell-substrate adhesions with the actin cytoskeleton [40, 41].
Likely roles for Myo-II at apical (front) side of the border cell
cluster include retraction of protrusions [20], as well as
resolving protrusion dynamics from the pre- to postdetach-
ment phases of migration (this study). Our data do not explic-
itly support a role for Par-1 at the apical side of the cluster.
Moreover, in the absence of Par-1, we detected a low level
of phosphorylated MRLC/Sqh that was still partially localized.
Thus, Myo-II is activated by at least one other kinase in addi-
tion to Par-1.
We hypothesize that Par-1 promotes higher levels of Myo-II
activity at the basolateral side (back), whereas another kinase
activates Myo-II (and/or inactivates the phosphatase) specifi-
cally at the front. Rok can phosphorylate both MRLC and
myosin phosphatase [24, 25]. Knockdown of Rok by RNAi
significantly reduced p-MRLC/Sqh levels and disrupted
border migration. The combined depletion of both Par-1 and
Rok almost completely abolished detachment, suggesting
that the two kinases converge (directly or indirectly) on the
same target (Myo-II). Epithelial morphogenesis during
C. elegans embryonic elongation and Drosophila larval tissue
development require multiple kinases to optimally activate
Myo-II [42, 43]. Furthermore, different kinases have been
shown to regulateMRLC activation at discrete locations within
single migrating cells. For example, MLCK phosphorylates
MRLC at the front or leading edge, whereas Rok targets
Figure 6. Active Myo-II Is Polarized within the Border Cell Cluster
(A) Stage 9 wild-type egg chamber stained for Mbs (magenta), Par-1 (green), and DAPI to label nuclei. Mbs is uniform in the border cell cluster and overlaps
with Par-1 (white) at the basolateral (back), but not at the apical (front) (arrowheads).
(B) Frame from a time-lapse movie showing an intense Sqh:GFP foci (arrowhead) at the basolateral (back) of the cluster during detachment from an anterior
follicle cell (white arrow; observed in 7/9 movies).
(C and D) Polarized distribution of p-MRLC/Sqh in border cells.
(C) Border cell clusters are overlaid with the quadrants (dotted lines) used to measure fluorescence distribution (see Supplemental Experimental Proce-
dures). Brightness and/or contrast of images (from experiments shown in Figure 4) were adjusted for better visualization, but not used for quantification.
(D) Quantification of p-MRLC/Sqh distribution in the indicated genotypes.
(E and F) Molecular pathway (E) and model (F) for Myo-II activation at the basolateral (back) of border cells. See text for details.
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[14]. However, it remains to be determinedwhether Rok and/or
additional kinases have a polarized or more general role in
Myo-II activation in border cells.
Our study demonstrates that maintaining localized Myo-II
activity is a critical feature of collective cell detachment and
motility and identifies the conserved polarity kinase Par-1 as
a key new regulator of this pathway. Active Myo-II is polarized
within the border cell cluster, rather than in individual border
cells, emphasizing that asymmetrically activated Myo-II
contributes to collective behavior. Notably, in a model of
collective cancer cell invasion, high actomyosin activity at
cell-matrix contacts combined with low activity at contacts
between cells within the group, produced optimal contractile
force around the outside and thus promoted collective cell
movement [44]. It will be important to determinewhether verte-
brate Par-1 homologs also regulate actomyosin contractionduring processes that depend on collective cell motility,
such as wound healing or tumor invasion and metastasis.
Given that many metastasizing tumors detach from epithelia
both as single cells and collective groups, it will be important
to further probe themechanisms of myosin-mediated contrac-
tion in this process.Experimental Procedures
Drosophila Genetics
Crosses were performed at 25C, except tsGAL80 crosses were performed
at 18C. Flies were incubated at 29C for R14 hr before dissection for
optimal GAL4/UAS transgene expression. Strain information is in the
Supplemental Experimental Procedures. GAL4 lines outcrossed to w1118
were used as controls. The genotype for Par-1 RNAi (Strong) is c306-
GAL4/+; +/par-127C1; +/UAS-Par-1 RNAi and for Par-1 RNAi (Weak) is
c306-GAL4/+; +/UAS-Par-1 RNAi. Sqh RNAi (Strong) genotype is sqhAX3
/+; UAS-Sqh RNAi/+; equivalent phenotypes were obtained with UAS-Sqh
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371RNAi (tsGAL80). Mosaic mutant clones of sqhAX3 [17] and rok2 [15] were
generated with the FLP/FRT system using flies of the genotype ubi-
mRFP.nls, hsFLP, FRT 19A.
Immunofluorescence and Live Imaging
Ovary dissection and staining methods were performed as described [8].
Fixation was in 4% formaldehyde in phosphate buffer (pH 7.4) for 10 min;
for p-MRLC/Sqh staining, ovaries were fixed in 8% formaldehyde in PBS
for 5 min. The following primary antibodies were used: rat anti-DE-cadherin
1:25 (DCAD2; Developmental Studies Hybridoma Bank, DSHB); mouse
anti-a-tubulin 1:400 (DM1A, Sigma); guinea pig anti-Par-1 1:10 [8]; rabbit
anti-Mbs 1:1000 (from C. Tan); rabbit anti-pSer19 MRLC 1:10 (p-MRLC/
Sqh; Cell Signaling Technologies). Secondary antibodies or phalloidin (to
label F-actin) conjugated to Alexa Fluor 488 or Alexa Fluor 568 (1:400; Invi-
trogen) were used. DAPI (0.05 mg/mL; Sigma) was used to stain nuclei.
Ovary dissection, live culturing, and time-lapse imaging were performed
as described [7]. Imaging was performed on a Zeiss AxioImager Z1 motor-
ized upright microscope with a Zeiss Colibri LED light source (live imaging),
or HXP 120 light source and the ApoTome system (fixed samples), and
a Zeiss AxioCam MRm CCD camera controlled with AxioVision 4.8.2 soft-
ware. Movie S1 and Movie S2 were acquired using 75%–100% LED power
(LED module 540–580 nm) at 3 min intervals for 4–5 hr, using either
a Plan-Apochromat 20 3 0.75 numerical aperture (NA) or a Plan-Apochro-
mat 103 0.45 NA objective. For Movie S4 and Movie S5, time-lapse images
were captured using 25% LED power (LED module 455) at 10 s intervals for
30 min, and 10 z stacks were acquired at 0.5 mm intervals using a Plan-
Neofluar 40 3 1.3 NA oil objective. For Movie S3, images were acquired
on a Nikon TE-2000 microscope using a 20 3 0.75 NA objective and the
PerkinElmer UltraVIEW VoX spinning disk confocal with a Hamamatsu
cooled 14-bit EMCCD C9100-50 camera controlled by PerkinElmer Volocity
software. Descriptions of the image analyses are in the Supplemental
Experimental Procedures.
Immunoprecipitation, Western Blot Analysis, and In Vitro Kinase
Assays
For immunoprecipitations, samples were lysed in homogenization buffer
(50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 2.5 mM EDTA, 0.1% Triton X-100)
supplemented with Halt protease and phosphatase inhibitor cocktail
(Thermo Scientific). Five micrograms of antibody IgG (rabbit anti-GFP or
anti-HA; Invitrogen) per milligram of magnetic Dynabeads Protein A (Invitro-
gen) were preincubated before adding lysate. Lysate was added to
antibody-bound beads and incubated at 4C overnight, washed in homog-
enization buffer, and prepared for SDS-PAGE followed by western blot
analysis using standard protocols. In vitro kinase assays were performed
as described [45] on isolated HA:Mbs protein using purified Par-1 kinase.
Details on sample preparation, antibodies, and western blotting are in the
Supplemental Experimental Procedures.
Supplemental Information
Supplemental Information includes four figures, Supplemental Experi-
mental Procedures, and fivemovies and can be found with this article online
at doi:10.1016/j.cub.2012.01.037.
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